Oweida S W, Roubin G S, Smith R B, Salam A A
Department of Surgery, Emory University School of Medicine, Atlanta, GA.
J Vasc Surg. 1990 Sep;12(3):310-5.
The threat of a vascular complication exists in association with any percutaneous arterial catheterization, but is greater in the more complex interventional techniques. During a 3 1/2-year period from January 1985 through June 1988, 4988 percutaneous transluminal coronary angioplasty procedures were performed at Emory University Hospital. All patients were given heparin during the cardiac intervention, and all had a catheter introducer left in place for several hours after completion of the procedure. Fifty-five iatrogenic vascular complications developed in 52 patients (1%), resulting in 54 corrective operations. Pseudoaneurysm, the most frequent complication, was seen in 35 patients (64%). This was followed by arteriovenous fistula in eight (15%), uncontrolled hemorrhage in six (11%), arterial thrombosis in three (6%), peripheral embolization in two (4%), and bowel ischemia in one patient. The outcome of surgical therapy in the entire group was quite acceptable with no operative mortality, no extremity amputation, and a 7.4% complication rate. Variables that correlated with an increased risk of peripheral vascular problems after percutaneous transluminal coronary angioplasty included advanced age, female gender, thrombolytic therapy, and postprocedural anticoagulation. Variables that did not appear to correlate were hypertension, diabetes, prior percutaneous transluminal coronary angioplasty, antiplatelet therapy, or the size of the guiding catheter used.
任何经皮动脉导管插入术都存在血管并发症的风险,而在更复杂的介入技术中这种风险更高。在1985年1月至1988年6月的3年半时间里,埃默里大学医院共进行了4988例经皮腔内冠状动脉成形术。所有患者在心脏介入治疗期间均接受肝素治疗,并且在手术完成后所有患者均留置导管导入器数小时。52例患者(1%)出现了55例医源性血管并发症,导致进行了54次矫正手术。最常见的并发症是假性动脉瘤,见于35例患者(64%)。其次是动静脉瘘8例(15%)、出血无法控制6例(11%)、动脉血栓形成3例(6%)、外周栓塞2例(4%),还有1例患者出现肠缺血。整个组手术治疗的结果相当令人满意,无手术死亡、无肢体截肢,并发症发生率为7.4%。与经皮腔内冠状动脉成形术后外周血管问题风险增加相关的变量包括高龄、女性、溶栓治疗和术后抗凝。似乎不相关的变量有高血压、糖尿病、既往经皮腔内冠状动脉成形术、抗血小板治疗或所用引导导管的尺寸。